PROVIDER PROFILE · NPI 1689817041

Kamal MandalapuM.D.

Hematology-OncologyAustell, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

395

Unique beneficiaries

—

Total services

623

Distinct HCPCS

Medicare payment

$46K

Peer benchmark

Total Medicare services vs. 236 Hematology-Oncology providers in GA — below median (cohort median 1,046).

PRESCRIBING · PART D · 2024

Total Rx claims

975

Beneficiaries

—

Total drug cost

$2.9M

Distinct drugs

Brand share

44.2%

Top prescribed drugs

Prochlorperazine Maleate99 claims

Ondansetron Hcl91 claims

Letrozole68 claims

Prednisone50 claims

Zanubrutinib43 claims

QUALITY · MIPS · 2024

Final MIPS score

93.9

Quality

82.1

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.80%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$10K

Payment records

197

By payment type

Consulting Fee$6K

Food and Beverage$4K

Travel and Lodging$180

Education$108

REFERRAL NETWORK

Where Kamal Mandalapu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HOSPITAL AUTHORITY OF VALDOSTA AND LOWNDES COUNTY GEORGIA	81	474
Lillian Burke Medical Oncology · Eden, NC	39	188
Jennifer Stevick Nurse Practitioner · Valdosta, GA	33	119
Andrew Spell Diagnostic Radiology · Gainesville, FL	14	27
COOPER, RICHARD	13	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history